Symbiosis^TM Pharma is Spark Holland's unique solution for integrated online SPE-LC-MS automation (XLC-MS). The system offers large flexibility in processing different types of samples selecting one of the three fully automated operational modes LC-MS; XLC-MS; AMD (Advanced Method Development). This application shows a fast method development for Chloramphenicol with the use of the AMD mode of Symbiosis Pharma together with the HySphere^TM method development cartridge tray (Spark p.n.0722.650).

Chloramphenicol was originally isolated from a species of Streptomyces bacteria. Its antibiotic activity results from its interference with protein synthesis in invading microbes. However, it is a very toxic substance, its most serious and potentially lethal effect being depression of red blood cell production in bone marrow; cases of leukemia were also attributed to early use of hloramphenicol. Because of its toxicity, Chloramphenicol is rarely prescribed for infections that can be treated by other antibiotics.

To view the full article please click here